Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Pharma Tech

Tremfya rescues J&J’s immunology sales to fuel strong Q3

Oct 13, 2026, 2:34 PM

Read Full Article → Tremfya rescues J&J’s immunology sales to fuel strong Q3

Tremfya rescues J&J’s immunology sales to fuel strong Q3

Translate article text

Choose a language and wait for the translated text.

Despite several products succumbing to generics and biosimilars, J&J raised its 2026 guidance.

Tremfya rescues J&J’s immunology sales to fuel strong Q3 | PharmaVoice